Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00085358
Status:
COMPLETED
Last Update Posted:
2019-07-22
First Post:
2004-06-10
Brief Title:
Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel Carboplatin and Paclitaxel in Treating Patients With Stage II Stage III or Stage IV Ovarian Epithelial Fallopian Tube or Primary Peritoneal Cavity Carcinoma Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Ovarian Epithelial Cancer |
| Brenner Tumor |
| Fallopian Tube Cancer |
| Ovarian Carcinosarcoma |
| Ovarian Clear Cell Cystadenocarcinoma |
| Ovarian Endometrioid Adenocarcinoma |
| Ovarian Mixed Epithelial Carcinoma |
| Ovarian Mucinous Cystadenocarcinoma |
| Ovarian Serous Cystadenocarcinoma |
| Ovarian Undifferentiated Adenocarcinoma |
| Primary Peritoneal Cavity Cancer |
| Stage II Ovarian Epithelial Cancer |
| Stage III Ovarian Epithelial Cancer |
Keywords: